PharmaCyte Biotech Inc (PMCB)

[Peacefulwendy]

Nuvilex has the very credible, experienced with FDA approvals, Dr Von Hoff beginning trials this week with Cell-in-a-Box(R)technology.

"Kenneth L. Waggoner, CEO and President of Nuvilex, stated, "The start of these studies at TD2 is a banner day for Nuvilex. We are extremely gratified to have a prestigious organization such as TD2 performing these studies on our behalf. It should be noted that these studies represent the first time that any work, either preclinical or clinical, has been done in the United States with the Cell-in-a-Box(R) cellulose-based live cell encapsulation technology that has such exciting potential." Malignant ascites fluid in the abdomen contains cancer cells which can "seed" and form new tumors. Accumulation of this fluid is problematic for cancer patients and can cause significant discomfort. The current standard of care requires that malignant ascites fluid be removed from the abdomen of cancer patients at regular intervals."

http://finance.yahoo.com/news/nuvilex-begins-preclinical-studies-translational-130000579.html